Delivery Order SPE2DB24D1205-SPE2DB25FCXRL
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX VACCINE SYRINGEml, a hepatitis A and hepatitis B vaccine, with a ceiling value of $1,078.23 and a period of performance through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $100,636.46, is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and B vaccine, at a ceiling value of $1,481.68. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of TWINRIX Vaccine syringes, a vaccine used for the prevention of hepatitis A and hepatitis B. The contract has a ceiling value of $2,705.52 and runs through February 8, 2024. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the TWINRIX vaccine, a combined hepatitis A and hepatitis B vaccine, with a ceiling value of $7,895.37. The contract is a Firm Fixed Price (FFP) delivery order with a completion date of May 29, 2025. The contract is not set aside and is open to full and open competition. As...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,050.76 firm fixed-price contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine, to support defense medical requirements. The contract has a completion date of June 4, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $20,282.40 firm fixed-price contract is for the delivery of TWINRIX VACCINE SYRINGE ML, a combination vaccine used to prevent hepatitis A and hepatitis B. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the TWINRIX Vaccine, a hepatitis A and hepatitis B combination vaccine, in syringes. The contract is a firm fixed-price Delivery Order with a ceiling value of $1,248.05 and an ultimate completion date of May 30, 2025. The award does not utilize a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a vaccine product, with a ceiling value of $61,093.39 and a completion date of March 19, 2025. The contract is a Firm Fixed Price, Delivery Order type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the TWINRIX VACCINE SYRINGE, a combination hepatitis A and hepatitis B vaccine, with a ceiling value of $3,639.25 and a period of performance through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...